# Sublingual Misoprostol With or Without Intravenous Tranexamic Acid During Hemorrhagic Cesarean Section

> **NCT03774706** · NA · UNKNOWN · sponsor: **Aswan University Hospital** · enrollment: 150 (estimated)

## Conditions studied

- Cesarean Section Complications

## Interventions

- **DRUG:** Misoprostol
- **DRUG:** Tranexamic Acid
- **DRUG:** placebo to tranexamic acid

## Key facts

- **NCT ID:** NCT03774706
- **Lead sponsor:** Aswan University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-01-01
- **Primary completion:** 2021-12-30
- **Final completion:** 2022-01-31
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2019-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03774706

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03774706, "Sublingual Misoprostol With or Without Intravenous Tranexamic Acid During Hemorrhagic Cesarean Section". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT03774706. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*